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Abstract: To prepare the ESA (European Space Agency) spaceflight project “Wound healing and
Sutures in Unloading Conditions”, we studied mechanisms of apoptosis in wound healing models
based on ex vivo skin tissue cultures, kept for 10 days alive in serum-free DMEM/F12 medium
supplemented with bovine serum albumin, hydrocortisone, insulin, ascorbic acid and antibiotics
at 32 ◦C. The overall goal is to test: (i) the viability of tissue specimens; (ii) the gene expression of
activators and inhibitors of apoptosis and extracellular matrix components in wound and suture
models; and (iii) to design analytical protocols for future tissue specimens after post-spaceflight
download. Hematoxylin-Eosin and Elastica-van-Gieson staining showed a normal skin histology
with no signs of necrosis in controls and showed a normal wound suture. TdT-mediated dUTP-biotin
nick end labeling for detecting DNA fragmentation revealed no significant apoptosis. No activation
of caspase-3 protein was detectable. FASL, FADD, CASP3, CASP8, CASP10, BAX, BCL2, CYC1, APAF1,
LAMA3 and SPP1 mRNAs were not altered in epidermis and dermis samples with and without a
wound compared to 0 day samples (specimens investigated directly post-surgery). BIRC5, CASP9,
and FN1 mRNAs were downregulated in epidermis/dermis samples with and/or without a wound
compared to 0 day samples. BIRC2, BIRC3 were upregulated in 10 day wound samples compared
to 0 day samples in epidermis/dermis. RELA/FAS mRNAs were elevated in 10 day wound and no
wound samples compared to 0 day samples in dermis. In conclusion, we demonstrate that it is possible
to maintain live skin tissue cultures for 10 days. The viability analysis showed no significant signs of
cell death in wound and suture models. The gene expression analysis demonstrated the interplay
of activators and inhibitors of apoptosis and extracellular matrix components, thereby describing
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important features in ex vivo sutured wound healing models. Collectively, the performed methods
defining analytical protocols proved to be applicable for post-flight analyzes of tissue specimens after
sample return.
Keywords: skin; wound healing; suture; apoptosis; caspases; extracellular matrix proteins
1. Introduction
In the near future, more space exploration programs and commercial spaceflights will lead to
longer space missions, an elevated number of crew members and space travelers on board, as well as
an increase in on-board and extravehicular activities. This will elevate the risks of traumatic injuries
and emergencies in space. A critical aspect in surviving a trauma or a surgery is sufficient wound
healing, which depends on a healing process and suture behavior in space.
Wound healing is a complex process consisting of three partially overlapping phases:
inflammation, tissue formation, and tissue remodeling [1,2]. Hence, it involves a series of cell
populations that play specific roles at different stages of the repair process, e.g., immune cells are
crucial in the early inflammatory phase, when their proliferation strongly increases [3,4].
A proper sequence and timing of events is very important for a successful repair. Among various
biochemical and physiological factors affecting wound healing, the mechanical factors play a significant
role. These are skin tension, mechanical forces at the wound margins and mechanical stress produced
by stitches (when a suture is necessary). In addition, wound contraction due to myofibroblasts has a
strong influence on the development of the repair process and scar quality [5]. During the different
phases of wound healing, apoptosis balances cell growth and acts to eliminate cell populations that
already completed their specific tasks without causing tissue damage or inflammatory reaction [6,7].
As mentioned by Drudi et al. in their “state of the art” report concerning space surgery from
2012 [8], tissue repair mechanisms, wound healing and suture behavior have been poorly studied
in the space environment, characterized by unloading conditions. The literature on these topics,
while certainly not exhaustive, reports conflicting results [9,10]. However, the various studies indicate
that weightlessness can induce impairments in repair processes [11–14] and alters the behavior of
the cell populations involved in tissue repair [15–17]. The risk of wound healing complications
following traumatic events and emergency surgery in space is therefore an important health concern
for space agencies.
The project “Wound Healing and Sutures in Unloading Conditions”, selected by the European
Space Agency (ESA) in the context of the International Research Announcement for Research in Space
Life Sciences (ILSRA-2014) at the International Space Station (ISS), aims to study the behavior and
healing of wounds and sutures in unloading conditions in space. The project is based on human tissue
cultures from consenting patients who underwent abdominoplasty. The small tissue specimens are
secured to suitable frames to apply a tension similar to the physiological conditions and subsequently
wounded and sutured.
The study here presented is part of activities aiming to prepare the inflight space experiment.
The principal aim is the evaluation of apoptosis and necrosis in skin tissue samples cultured in
serum-free medium for 10 days.
Human skin cultures had been extensively studied because skin autografts are used to treat
severe burns. Therefore, preservation conditions and tissue viability are very important for optimal
clinical results. Even if the storage progressively affects the cellular component of the tissue, suitable
temperature values and culture media allow to maintain an acceptable tissue viability for more than
4 weeks, while a significant deterioration had been observed after 35 days [18].
Full-thickness skin cultures can be also regarded as interesting scientific model for wound healing
studies. To carry out experiments on the ISS successfully, it is very important to ascertain the survival
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of the samples for a sufficient amount of time, i.e., at least 10 days. The assessment of apoptosis and
necrosis is considered a valuable way to obtain information on tissue damage and its adaptation to the
in vitro conditions [19,20]. Moreover, since apoptosis is involved in the regulation of wound healing [6],
the monitoring of apoptosis in wound healing models can provide insights into the evolution of the
repair process.
The first phases of wound repair comprise haemostasis (platelet accumulation, coagulation) and
inflammation, which is characterized by migration of immune cells and fibroblasts in the wounded
area. A fibrin–fibronectin clot is detectable in areas of active bleeding after injury [21]. It interacts with
various cells involved in wound repair and plays a key role in extracellular matrix (ECM) formation.
Great amounts of cytokines and growth factors are produced, fibroblasts and keratinocytes take an
activated phenotype [2]. Neutrophils entering the wound area eliminate microorganisms, then they
will become apoptotic, and will be finally consumed by macrophages, a process without further
inflammation. Macrophages, play a fundamental role in the transition between inflammation and
repair [22]. In this early phase, the process of apoptosis will start as early as 12 hours after wound
injury [23].
The following intermediate stage (proliferation phase) is characterized by keratinocyte
proliferation and migration. In addition, fibroblasts proliferate, ECM is synthesized and deposits are
visible, and the process of angiogenesis is started. Apoptosis is important for normal wound healing,
especially in the removal of inflammatory cells and others like endothelial cells and the transformation
of granulation tissue into scar tissue [22]. These cell populations are rapidly proliferating during
tissue repair. The process of apoptosis keeps cell growth in balance. Apoptosis in myofibroblasts is
initiated on day 12, peaks at day 20, and is resolved at day 60 [23]. Normal mice exhibit an inverse
relationship between BCL2 and p53 over time. Directly after injury, the BCL2 mRNA is elevated and
p53 down-regulated to allow proliferation of the cells, which is an important step for wound repair [24].
During the time course, BCL2 levels were down-regulated, while contrarily the p53 mRNAs were
up-regulated to reduce the proliferative response.
The late stage of wound healing (tissue remodelling) is characterized by ECM remodelling with
scarring. The complete biological process is tightly controlled by multiple cell types secreting growth
factors, cytokines, and soluble factors into the interstitial space to achieve a closure and a functional
restoration of the barrier. The apoptosis of the involved cells is a key factor for wound repair regulation.
Due to ex vivo culturing conditions, serum- and blood-derived signaling molecules and immune
cells are absent in this approach. Thereby, a direct deduction of our findings on known functions of
apoptosis in wound healing is not applicable [6]. As already applied in further studies [25], our primary
focus is apoptosis, as a surrogate for cell viability. Nevertheless, stated findings display new insights in
cell viability and the interplay of apoptotic effector proteins on ECM proteins and NF-κB. An essential
role of fibronectin is indicated for all phases of wound healing [21]. Thus, fibronectin is known to affect
inflammation by modulating macrophage activation [1]. Whereas, an increase in fibronectin gene is
found in abnormal wound healing, e.g., keloids [26]. Fibronectin influences ECM-functionality, by its
connection to further essential ECM proteins, e.g., actin or laminin, via integrin receptors [27].
To prepare the future ESA spaceflight mission, we searched for apoptosis and necrosis and
studied mechanisms of apoptosis in wound healing models based on ex vivo skin tissue cultures.
Therefore, this study aims (i) to characterize the morphological changes and to test the viability of the
tissue specimens; (ii) to determine the gene expression of activators and inhibitors of apoptosis with
focus on the extrinsic and intrinsic pathways of apoptosis and extracellular matrix (ECM) components
in wound and suture models, including to analyze the interaction network of the genes of interest using
STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) analysis and (iii) to design the
analytical protocols which will be performed in the future on tissue specimens after the post-spaceflight
download of the samples.
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2. Results and Discussion
Providing adequate medical care in space, close to the terrestrial standards, is one of the challenges
to be addressed in future space exploration programs. Emergency and space surgery is a relatively little
studied area of space medicine that will be increasingly important for the future of space exploration
with long-term missions. The purpose of the project “Wound Healing and Sutures in Unloading
Conditions” is to get insights, which contribute to fill this gap. However, the in-flight experiment—that
is the monitoring of suture behavior and healing in unloading conditions—requires meticulous
preparation and preliminary studies on ground. An important prerequisite for the success of the
experiment is the viability of the suture models for a sufficiently long time.
2.1. Characterization of the Morphological Changes and Testing the Viability of the Tissue Specimens
To answer the question, whether skin samples obtained from patients who underwent
abdominoplasty surgery can be kept alive in a special medium for 10 days, we focused on cell
death changes in these samples.
The macroscopic overview of the skin samples with and without a suture revealed only some
puckering and no visible signs of necrosis as demonstrated in Figure 1.
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Figure 1. Photo coverage of full-thickness skin grafts of patient 1 (20 × 20 mm) fixed on frames made 
of surgical steel immediately after preparation (0 day). Pictures show samples immediately after 
explant dissection, as well as at 2, 4, 6, 8 and 10 days after mounting. All explants belong to the same 
donor. Non-wounded (a) and wounded simple interrupted sutured samples (b) are shown. No 
sample shows signs of necrosis, inflammation or disintegrated tissue. 
Normally necrosis occurs when cells are exposed to a trauma followed by rapid disintegration. 
Apoptosis is a more orchestrated process that, in many cases, is functional to other biological 
processes. Necrosis and altered apoptosis mechanisms are detrimental and are indicative of a 
defective suture healing. Therefore, the presence of necrotic cells and apoptosis dysregulation will be 
analyzed in this suture model as a spaceflight preparatory study. For this purpose, the samples were 
embedded in paraffin and sections for histochemical staining were prepared. Hematoxylin–eosin 
(HE) staining [28,29] revealed no signs of necrosis in all specimens (Figure 2a–c,g–i,m–o). Elastica-
van-Gieson staining [30] showed intact elastic fibers in the skin tissues cultured for 10 days in 
medium (Figure 2d–f,j–l,p–r). 
Figure 1. Photo coverage of full-thickness skin grafts of patient 1 (20× 20 mm) fixed on frames made of
surgical steel immediately after preparation (0 day). Pictures show samples immediately after explant
dissection, as well as at 2, 4, 6, 8 and 10 days after mounting. All explants belong to the same donor.
Non-wounded (a) and wounded simple interrupted sutured samples (b) are shown. No sample shows
signs of necrosis, inflammation or disintegrated tissue.
Normally necrosis occurs when cells are exposed to a trauma followed by rapid disintegration.
Apoptosis is a more orchestrated process that, in many cases, is functional to other biological
processes. Necrosis and altered apoptosis mechanisms are detrimental and are indicative of a
defective suture healing. Therefore, the presence of necrotic cells and apoptosis dysregulation will
be analyzed in this suture model as a spaceflight preparatory study. For this purpose, the samples
were embedded in paraffin and sections for histochemical staining were prepared. Hematoxylin–eosin
(HE) staining [28,29] revealed no signs of necrosis in all specimens (Figure 2a–c,g–i,m–o).
Elastica-van-Gieson staining [30] showed intact elastic fibers in the skin tissues cultured for 10 days in
medium (Figure 2d–f,j–l,p–r).
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EvG (j–l); 0.5× (g,j), 3.5× (h,k) and 11.5× magnification (i,l)) and 10 days wounded (HE (m–o); EvG 
(p–r); 0.5× (m,p), 3.5× (n,q) and 11.5× magnification (o,r)). Wound edges are identified with arrows 
and arrowheads. Arrowheads show wound edge area at 11.5× magnification, in accordance with areas 
at 3.5× magnification. 
Apoptosis is involved in the pathogenesis of a variety of diseases, such as cardiac injury [31], 
infections, transplant rejections, tumor responses to chemotherapy and/or radiotherapy and is also 
detectable in microgravity [31–36]. Nevertheless, apoptosis bears crucial functions in morphogenesis 
and organ development. The known mechanisms of apoptosis were reviewed by Schoenberger et al. 
[32] and Fuchs and Steller [37]. Here we use this knowledge to examine whether some of the 
inhibitors or inducers of programmed cell death are activated during the storage of the skin 
specimens and to investigate their gene expression pattern in ex vivo wound healing. 
The morphological changes of programmed cell death were first described by Kerr et al. in 1972 
[38]. The authors described alterations in cells different from necrotic alterations, such as cell 
shrinkage, chromatin condensation as well as membrane blebbing [38]. The process of apoptosis 
comprises a complex mechanism in which a large number of pro-apoptotic and anti-apoptotic factors 
Figure 2. Hematoxylin–eosin (HE) and Elastica-van-Gieson (EvG) staining of patient 1 show vital
skin structure at all times of investigation without necrosis or inflammation: reference samples, 0 day
(HE (a–c); EvG (d–f); 0.5× (a,d), 3.5× (b,e) and 11.5×magnification (c,f)), 10 days non-wounded (HE
(g–i); EvG (j–l); 0.5× (g,j), 3.5× (h,k) and 11.5×magnification (i,l)) and 10 days wounded (HE (m–o);
EvG (p–r); 0.5× (m,p), 3.5× (n,q) and 11.5× magnification (o,r)). Wound edges are identified with
arrows and arrowheads. Arrowheads show wound edge area at 11.5×magnification, in accordance
with areas at 3.5×magnification.
Apoptosis is involved in the pathogenesis of a variety of diseases, such as cardiac injury [31],
infections, transplant rejections, tumor responses to chemotherapy and/or radiotherapy and
is also detectable in microgravity [31–36]. Nevertheless, apoptosis bears crucial functions in
morphogenesis and organ development. The known mechanisms of apoptosis were reviewed by
Schoenberger et al. [32] and Fuchs and Steller [37]. Here we use this knowledge to examine whether
some of the inhibitors or inducers of programmed cell death are activated during the storage of the
skin specimens and to investigate their gene expression pattern in ex vivo wound healing.
The morp ological changes of programmed cell death were first described by K rr et al. in 1972 [38].
The author describ d alter t ons in cells differe t from necr tic al erations, such as cell shrinkage,
chromatin condensation as well as membrane blebbing [38]. The process of apoptosis comprises a
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complex mechanism in which a large number of pro-apoptotic and anti-apoptotic factors interact in a
specific manner. If present, necrotic areas together with inflammation and edema would have been
detected easily by HE staining (Figure 2).
Morphological signs of apoptosis can be detected by application of the terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) technique. In addition, 4′,6-diamidino-2-phenylindole
(DAPI) staining was performed (Figure 3a–d). We applied this method and demonstrated that
only a few cells in the skin tissue samples became apoptotic during the culture. As positive control,
human tonsil samples were used. These specimens normally reveal various apoptotic cells. Palatine
tonsil positive controls (Figure 3d) show clear differences to TUNEL staining in the skin samples.
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Figure 3. Detection of apoptosis in human full-thickness skin graft cross sections: TUNEL staining
merged with DAPI counterstaining was used for apoptosis detection. Full-thickness skin grafts derived
from explants from three patients who underwent abdominoplasty were investigated. Reference control
(a) was taken at the day of surgery, 0 day. Apoptosis detection by fluorescence microscopy in
unwounded (b) and wound skin samples (c) after 10 days of organ cultur . Palatine tonsil cross
section was sed as positive control (d). All shown skin samples are r ved from patient 1.
Semi-quantitative analysis of TUNEL-positive stained area (e). The standard deviation is indicated for
each sample.
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In contrast, necrosis can be shown by propidium iodide (PI), a fluorescent intercalating agent used
as a DNA stain. It is useful to detect necrotic cells [39]. Wounds caused by physical agents (trauma or
burns) can become necrotic in case of bacterial infection or inflammation. Therefore, it is necessary
to avoid infection and thus to prevent necrosis. Due to formaldehyde fixation of our cells, all cells
are PI positive. The staining was utilized for morphological apoptosis assessment. We could show
that no apoptosis related signs of morphological changes, like membrane blebbing, cell shrinkage or
apoptotic bodies were visible in the skin samples. PI staining of the tissues is shown in Figure 4 and
demonstrates no appearance of apoptosis in all specimens.
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Figure 4. Propidium iodide (PI) staining in human full-thickness skin graft cross sections: No significant
nuclear changes were detectable in the skin samples by PI-staining. A reference sample fixed at the
day of surgery, 0 day (a,e), as well as a non-wounded (b,f) and wounded skin (c,g) sample cultured
in organ culture medium for 10 days are shown. Palatine tonsil was used as positive control (d,h).
All samples are shown in low (a–d) and high magnification (e–h).
Taken together, the morphological investigations did not reveal any significant signs of necrosis.
We could not detect any significant apoptosis in this experimental setting. To further examine the
quality of the ex vivo skin samples, we focused on the gene expression level of apoptosis genes
belonging to the extrinsic and intrinsic pathways of apoptosis.
2.2. Determination of the Gene Expression of Activators and Inhibitors of Apoptosis (Extrinsic an Intrinsic
Pathways of Apoptosis) and Extracellular Matrix Components in Wound and Suture Models, Including
Analysis of the Interaction Network of the Genes of Interest
2.2.1. Gene Expression of Activators and Inhibitors of Apoptosis
Membrane-associated proteins like the death receptors FAS/CD95 and the receptors for the
tumor necrosis factors (TNF-R) are involved in the extrinsic pathway of programmed cell death.
They cause cell death after ligand-receptor binding [37,40–42]. The transcription of genes involved in
the regulation of programmed cell death was investigated using quantitative real-time PCR (qPCR).
The investigation of the FAS (also called FAS-receptor) gene expression (Figure 5a,b) revealed
no cha ge in FAS mRNA in the wound sample (epidermis) comp red to the control samples with no
wound (0 and 10 d ys). In contrast, the FAS mRNA was significantly elev ted n 10 days samples
wit d without a wound in the dermis compared with 0 day (Figure 5b). In addition, no significant
changes we e found for FASL in all groups in the epidermis and dermis (Figure 5a,b). FASL is the
lig nd for the FAS-receptor and its binding to FAS results in apoptosis mediated by caspase activation.
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Interestingly, the TNFA and TNFB mRNAs were not detectable in all epidermis and dermis
samples with/without wounds (data not shown). The binding of FASL results in FAS trimerization,
which recruits the initiator caspase-8 via Fas-associated death domain protein (FADD). The FADD gene
expression was not changed in all groups in the epidermis and dermis (Figure 5a,b).
A plasma membrane-associated death-inducing signaling complex (DISC) converts procaspase-8
into the mature active caspase-8 [43,44]. The activation of caspase-8 leads to the activation of the
effector caspase-3 [44]. qPCR analyses revealed no significant changes in the CASP8 mRNA expression
between controls and sutured samples in the epidermis and dermis (Figure 5a,b).
Moreover, CASP10 gene expression was not changed in the epidermis, whereas in the dermis a
significant elevation of CASP10 mRNA was measured in 10 days samples without a wound compared
with 0 day (Figure 5a,b).
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The Western Blot analysis of caspase-3 revealed no activation of caspase-3 protein in the epidermis
and dermis (Figure 6a). This result is consistent with our qPCR results for CASP3. We measured no
significant changes for the CASP3 gene expression in the epidermis and dermis. (Figure 6b).
Activated caspase-8 induces programmed cell death via two parallel cascades. The first option
is the direct cleavage and activation of caspase-3. Secondly, it can cleave BID, a pro-apoptotic BCL2
family protein. The cleaved BID now termed truncated Bid (tBID) translocates to mitochondria,
inducing cytochrome c release, which sequentially activates caspase-9 and -3.
Therefore, the next step was to focus on the gene expression of cytochrome c. These data are given
in Figure 7a,b. The CYC1 gene expression in the epidermis and dermis was not significantly altered.
In addition, we examined the expression of the apoptotic protease activating factor 1, also known as
APAF1 (Figure 7a,b). It is involved in the cytochrome-c-dependent activation of caspase-3 (intrinsic
pathway of apoptosis, as shown in Taylor et al. [45]). There was no significant change between no
wound samples (0 and 10 days) in the epidermis and dermis. In the wound samples, there was a large
standard deviation for APAF1 detectable (Figure 7a,b).
Changes in the CASP9 gene expression were generally characterized by down-regulation after
10 days compared with reference samples (Figure 7a,b).
BAX, the BCL2-associated X protein, stimulates the release of cytochrome c from mitochondria,
while BCL2 is acting anti-apoptotic [46]. The BAX gene expression was not significantly changed in
epidermis and dermis samples (Figure 7a,b). In addition, also the BCL2 mRNA was not significantly
changed in all samples of the 5 patients (Figure 7a,b).
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irreparable [48]. Transient inhibition of p53 supports the early cell proliferation required for a rapid 
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In the epidermis, expression of p53 was significantly downregulated in 10 days no wound 
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Figure 6. Investigation of caspase-3: changes in the protein content of pro-caspase-3 and cleaved
caspase-3 (a). The amount of protein was investigated in reference controls (0 d), non-wounded and
wounded samples. As a positive control for apoptosis CX+ cells were utilized. 3T3 protein was used as
a cytoskeletal control. β-actin (loading control), pro-caspase-3 and cleaved caspase-3 were investigated
independently in dermal and epidermal tissue for the same skin samples. Quantitative real-time PCR
of CASP3 gene expression revealed no changes (b).
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We also investigated the tumor suppressor p53 (Figure 8a,b), which has various anticancer
functions and is involved in apoptosis, genomic stability, and inhibition of angiogenesis [47]. It can
activate DNA repair proteins, when the DNA has sustained damage. Thus, it may be also an important
factor in aging. p53 can initiate programmed cell death if DNA damage proves to be irreparable [48].
Transient inhibition of p53 supports the early cell proliferation required for a rapid tissue repair [49].
In the epidermis, expression of p53 was significantly downregulated in 10 days no wound samples
co pared to reference controls, 0 day (Figure 8a). In the dermis, there was no significant change
measureable (Figure 8b).
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In addition, we investigated the expression of NF-κB (nuclear factor κ-light-chain-enhancer of
activated B cells), which is a protein complex that controls transcription of DNA, cytokine production
and cell survival. NF-κB is involved in cellular responses to stimuli such as stress, cytokines,
ultraviolet irradiation etc. NF-κB plays a key role in regulating the immune response to infection [50].
Incorrect regulation of NF-κB has been linked to cancer, inflammatory and autoimmune diseases,
septic shock, viral infection, and improper immune development [51]. NF-κB incorporates a variety
of transcriptional regulatory functions and is known to be of great importance in apoptosis. It is
inactivated, by binding to I-κB (inhibitor of NF-κB). However, degradation of I-κB can result in a
translocation of NF-κB into the nucleus, where it can activate the transcription of anti-apoptotic
genes. The transcription factor p65, also known as the nuclear factor NF-κB p65 subunit, is a protein
that in humans is encoded by the RELA gene. RELA is a REL-associated protein involved in NF-κB
heterodimer formation, nuclear translocation and activation. NF-κB is an essential transcription
factor complex involved in all types of cellular processes, including cellular metabolism, chemotaxis
and more.
The data for RELA or NF-κB-subunit expression is given in Figure 8a,b. In the epidermis,
RELA expression was slightly, but insignificantly elevated in 10 days samples with and without
a wound (Figure 8a). In the dermis, RELA mRNA revealed a significant up-regulation in 10 days
samples with and without a wound compared to 0 day (Figure 8b).
The presence of NF-κB subunits, such as RELA, in the epidermis inhibits epithelial cell death
induced by Fas ligand, tumor necrosis factor-α, and microbes [52–54]. One mechanism by which
NF-κB protects cells from apoptosis is the induction of expression of anti-apoptotic genes such as
cellular inhibitors of apoptosis.
In a next step, we focused on an important part of the apoptotic machinery and investigated
the inhibitor of apoptosis protein (IAP) family. IAPs are involved in regulating caspase activity,
proliferation and survival of cells through binding to their baculovirus IAP repeat (BIR) domains [55].
First, we investigated the gene expression of BIRC2, which is the gene of the Baculoviral IAP
repeat-containing protein 2. This multi-functional protein regulates not only caspases and apoptosis,
but also modulates inflammatory signaling and immunity, mitogenic kinase signaling, and cell
proliferation, as well as cell invasion and metastasis [56,57]. BIRC2 has been shown to interact
with CASP9. Baculoviral IAP repeat-containing protein 2 inhibits apoptosis by binding to tumor
necrosis factor receptor-associated factors TRAF1 and TRAF2, probably by interfering with activation
of ICE-like proteases. BIRC 2 inhibits the activation of caspases-3, -7 and -9 [55].
We detected a significant increase in the BIRC2 gene expression of wound tissues vs. 0 day
controls in the epidermis (Figure 8a). In the dermis, the BIRC2 mRNA was upregulated in both 10 dsya
samples without and with wound compared with 0 day (Figure 8a).
Second, we also focused on BIRC3. The Baculoviral IAP repeat-containing protein 3 is a protein
that in humans is encoded by the BIRC3 gene. It is acting similar as BIRC2 and inhibits the activation
of caspase-3 as well as -7 and -9 [55]. This gene encodes a member of the IAP family of proteins that
inhibits apoptosis by binding to tumor necrosis factor receptor-associated factors TRAF1 and TRAF2.
BIRC3 gene expression patterns showed strong parallels to BIRC2. Interestingly, the samples showed
significant increases in no wound and wound tissues vs. 0 day controls in both dermis and epidermis
(Figure 8a,b).
Third, survivin, also called baculoviral inhibitor of apoptosis repeat-containing 5 or BIRC5, is a
protein that, in humans, is encoded by the BIRC5 gene. Survivin is a member of the inhibitor of
apoptosis (IAP) family. The survivin protein inhibits caspase activation and functions as a negative
regulator of programmed cell death. In addition, it also regulates the cell cycle [58]. Survivin acts
on cytokinin and mitotic spindle formation to inhibit apoptosis [55]. The BIRC5 gene is expressed
in normal adult tissues, including skin, but also in cancer cells such as follicular thyroid cancer
cells [35,59]. It is mostly detected in the nucleus of keratinocyte stem cells (KSCs) [60], but it is also
expressed in melanocytes [61]. Survivin has an important role in the regulation of cell cycle [60],
Int. J. Mol. Sci. 2017, 18, 2604 11 of 22
and is involved in promoting UV-induced melanoma development in vivo [61]. BIRC5 was found
to be downregulated, where significant changes in its gene expression were detected (Figure 8a) in
epidermis samples. A significant decrease of BIRC5 gene expression was found in no wound samples
vs. 0 day controls in the dermis (Figure 8b).Int  J. Mol. S i. 2017, 18, 2604 11 of 22 
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These data clearly demonstrate no differential regulation of apoptosis genes of the extrinsic
and intrinsic pathways of apoptosis in this ex vivo skin model after 10 days post-surgery (Figure 9).
Histopathological investigations revealed no relevant damage of the skin samples.
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2.2.2. Gene Expression Profile of Extracellular Matrix Proteins
Laminins are glycoproteins and part of the collection of biochemical molecules that form the
extracellular matrix (ECM). They are important for the control of biological processes, such as
proliferation, differentiation, adhesion and migration [62]. They are key players in tissue homeostasis,
wound healing and angiogenesis [63]. Laminins can be detected in all basal laminas. They possess
binding sites to surface receptors. Together with collagen type IV, entactin and perlecan they form the
basal lamina. Further players in the field are fibronectin and proteoglycans.
Knowledge of the behavior of ECM proteins in wound healing processes is very important and
has a great potential to help identifying new strategies for the enhancement of normal wound closure
and the treatment of chronic/non-healing wounds. Here, we detected no significant change in the
LAMA3 gene expression in both epidermis and dermis samples with and without a suture after 10 days
(Figure 10a,b).
The ECM protein fibronectin is involved in cell growth, migration, cell adhesion and
differentiation processes. It plays an important role in wound healing and development. Changes in
the expression of fibronectin have been reported in several diseases, such as diabetes, ischemia and
reperfusion [64], as well as other cardiovascular disorders or cancers. Rats with diabetes revealed
scarring and an increase in fibronectin-positive material in the cardiac left ventricular interstitium [28].
Moreover, it is known that intraluminal treatment with vascular endothelial growth factor (VEGF) is
beneficial to the healing process in vascular microsurgery [65,66]. Fibronectin protein was elevated
in a rat model with a vascular anastomosis and further induced by VEGF after 10 days post-surgery,
which was paralleled by an elevation of osteopontin and various collagen subtypes [65]. The FN1
mRNA was significantly decreased in the epidermis in the 10 days no wound sample, whereas no
significant change was detectable to the wound (Figure 10a). The FN1 mRNA was significantly reduced
in both 10 days groups compared with the 0 day samples in the dermis (Figure 10b).
The expression of fibronectin and laminin, which are assessed in the phase of the experiment
preparation to ascertain the viability of the tissue samples, will be analyzed in depth after the
flight, because studies on fibroblasts and endothelial cells grown in simulated microgravity have
shown marked alterations in production and three-dimensional organization of these ECM proteins,
whose dysregulation could strongly affect the healing process [16].
Osteopontin (SPP1) belongs to the group of small integrin-binding ligand N-linked glycoproteins
and acts as a cell adhesion molecule. Osteopontin is expressed in various cells such as bone cells,
chondrocytes, endothelial cells and cancer cells. It is involved in several biological processes, where it
mediates migration and cell adhesion. Moreover, osteopontin has also been connected to inflammation,
where it is upregulated, atherosclerosis and the post-myocardial infarction remodeling process [67].
In our experimental setting, the SPP1 gene expression was not changed in skin samples with and
without a wound in the dermis and epidermis (Figure 10a,b).
This finding supports our further data and indicates that there is no apoptosis in the skin tissue
cultured for 10 days ex vivo in medium. It has been reported that an elevated osteopontin expression
is associated with increased myocyte apoptosis and myocardial dysfunction [68]. The authors showed
that osteopontin is acting via CD44 receptors and induces apoptosis in myocytes via the involvement
of the mitochondrial death pathway [68]. In summary, a concise overview of the qPCR results is given
in Table 1.
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Figure 10. Gene expression patterns of selected extracellular matrix proteins: altered mRNA expression
levels are shown for reference control (0 day), unwounded and wounded skin samples after ten days
in organ culture medium. LAMA3, FN1 and SPP1 mRNAs were investigated for epidermis (a) and
dermis (b) samples respectively; * p < 0.05 reference vs. no wound, ** p < 0.05 reference vs. wound.
Table 1. Fold changes in g ne expr ssion.
Gene Symbol
No Wound Wound
Epidermis Dermis Epidermis Dermis
extrinsic pathway
FASL 1.59 ± 0.89 0.96 ± 0.65 1.58 ± 0.97 1.45 ± 0.65
FAS 1.26 ± 0.76 5.08 ± 1.83 * 1.78 ± 2.04 3.63 ± 2.24 *
BIRC2 1.51 ± 0.42 1.93 ± 0.82 * 2.25 ± 1.32 * 1.98 ± 0.42 *
BIRC3 3.87 ± 2.70 * 8.10 ± 7.08 * 6.22 ± 5.50 * 7.41 ± 4.73 *
FADD 0.82 ± 1.12 1.23 ± 0.93 1.14 ± 1.71 1.05 ± 0.65
CASP8 1.88 ± 3.44 0.65 ± 0.43 1.18 ± 1.90 0.57 ± 0.43
CASP10 48.7 ± 107.9 1.89 ± 2.43 * 90.8 ± 201.9 0.32 ± 0.26
CASP3 1.10 ± 0.23 1.10 ± 0.42 1.00 ± 0.49 0.80 ± 0.26
intrinsic pathway
BAX 1.14 ± 0.49 1.73 ± 0.97 1.44 ± 1.16 2.41 ± 1.98
BCL2 0.84 ± 0.48 1.02 ± 0.61 2.26 ± 2.70 3.23 ± 3.57
CYC1 1.51 ± 1.37 0.76 ± 0.19 1.79 ± 1.77 0.84 ± 0.26
APAF1 0.91 ± 0.57 0.81 ± 0.70 3.90 ± 5.81 7.53 ± 13.04
CASP9 0.30 ± 0.17 * 0.38 ± 0.27 * 0.32 ± 0.27 * 0.33 ± 0.41
RELA 7.53 ± 8.46 2.96 ± 1.40 * 6.06 ± 6.50 2.79 ± 1.43 *
BIRC5 0.16 ± 0.21 * 0.14 ± 0.11 * 0.26 ± 0.36 * 0.58 ± 0.45
P53 0.35 ± 0.17 * 1.06 ± 1.07 0.86 ± 1.06 1.24 ± 1.74
ECM
LAMA3 0.77 ± 0.45 0.86 ± 0.48 0.87 ± 0.58 0.95 ± 0.51
FN1 0.59 ± 0.22 * 0.48 ± 0.25 * 0.77 ± 0.35 0.52 ± 0.26 *
SPP1 2.35 ± 2.71 3.54 ± 2.85 2.18 ± 1.83 4.17 ± 3.88
* p < 0.05 vs. day 0 control. For no wound vs. wound no significant changes were found.
2.2.3. Interaction Network of the Genes of Interest
The extensive investigation of apoptotic factors revealed no signs of an activation of intrinsic or
extrinsic pathways of apoptosis—the CASP3 expression was not differentially regulated. Western blot
analyses revealed no cleaved caspase-3. A similar result was found for CASP9. The reason for the
stability of Casp3 may be found by looking at the interaction network of the investigated genes
and their products. Therefore, we performed a STRING network analysis to further investigate the
functional interactions of genes and their products. The STRING analysis describes important features
and the potential mechanisms behind ex vivo wound healing and possible apoptosis. Figure 11 shows
that genes and their products, which are known to regulate apoptosis, interact on gene (yellow lines)
and gene product levels in various ways of favoring and attenuating apoptosis. Their netting appears
to be unaffected by CYC1 and only weakly influenced by components of the extracellular matrix.
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A strong regulatory effect is exerted by NF-κB. The NF-κB gene is upregulated and might have a
pivotal role [69]. In our experiments, RELA seems to inhibit apoptosis via two routes. Its product binds
to BCL2 (blue line), which is unregulated, but has a strong inhibitory effect on caspase-3 (red line with
terminal cross bar). In addition, it binds BIRC2 and BIRC3, both are upregulated. BIRC 2 and 3 can
inhibit caspase-3 (grey lines with terminal red cross bar). The other components of the network did not
indicate significant regulation in our experiments. Hence it appears reasonable that the upregulated
RELA, BIRC2 and BIRC3 genes could enforce the observed inhibition of apoptosis.Int. J. Mol. Sci. 2017, 18, 2604 14 of 22 
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Figure 11. Mutual regulation of apoptosis related genes. STRING (Search Tool for the Retrieval
of Interacting Genes/Proteins) network analysis shows functional interactions of genes and their
products investigated.
2.3. Design of the Analytical Protocols to Be Performed in the Future on Tissue Specimens after the
Post-Spaceflight Download of the Samples
After the spaceflight, the samples will be transported to the laboratories of the science team by the
ESA. There, photos from all samples will be taken to document the macroscopic view of the specimens
and to check for damaged samples. Afterwards, histological investigations will be performed according
to the procedures described in Section 2.1 to determine the morphological changes. In addition,
the viability status of the skin samples cultured in space or on Earth will be checked (Section 2.1).
The RNAlater-fixed samples will be examined by quantitative qPCR to determine the gene expression
of activators and inhibitors of apoptosis with a special focus on the intrinsic and extrinsic pathways
of apoptosis (Section 2.2.1). In addition, the gene xpression of ECM proteins will be measured
(Section 2.2.2). Thereafter, the interaction of these genes of interest will be evaluated by STRING
analyses (Section 2.2.3). These analytical protocols will be used post-spaceflight after download.
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3. Materials and Methods
3.1. Media, Supplements and Reagents
The following reagents were used to conduct the study: DMEM-F12 medium (Dulbecco’s
modified eagle medium/F12 nutrient mixture (Ham), 1/1) with L-glutamine (Gibco by life technologies,
Darmstadt, Germany); Dulbecco’s phosphate buffered saline (DPBS) with Ca2+ and Mg2+ (Gibco by life
technologies). We supplemented the following additives to the medium: G-penicillin (Sigma-Aldrich,
Munich, Germany); gentamicin (Sigma-Aldrich); amphotericin B (Gibco by life technologies); bovine
serum albumin (Sigma-Aldrich); hydrocortisone (Sigma-Aldrich); insulin (Sigma-Aldrich) and
L-ascorbic acid (Sigma-Aldrich). For transport or short storage, the tissue was stored in RPMI-1640
medium (Roswell Park Memorial Institute medium, Gibco by life technologies, Darmstadt, Germany)
supplemented with lincomycin (lincomycin hydrochloride, Sigma Aldrich), colistin (colistin sulfate
salt, Sigma-Aldrich) and vancomycin (Vancomycin HCL, AG Scientific. Inc., San Diego, CA, USA).
3.2. Tissue Preparation and Organ Culture
Full-thickness skin samples of five patients were obtained from abdominoplasty surgery.
All patients gave their informed consent to include their explants into the study. The study was
approved by the ethics committee of the Medical Faculty of the Otto-von-Guericke-University
Magdeburg (Reference number AZ 128/16, 5 September 2016) and was conducted following rules
of the local ethics committee. The tissue specimens included into this study were obtained from
patients who underwent plastic surgery procedures after massive weight loss using gastric banding
or comparable activities. The explant consisting of epidermis, dermis and subcutaneous tissue was
stored in a sterile bag and maintained at 4 ◦C directly afterwards.
Immediately after the operation, the subcutaneous fat tissue was removed and previously
dissected full-thickness skin grafts were rinsed in DPBS. For sample size standardization, the prepared
samples were cut into squares with a side length of 20 mm. Thus, the surface area for each individual
sample was about 400 mm2 (organ culture samples). Subsequently, all specimens were knotted
on surgical steel frames to simulate physiological tissue tension (Ethicon (Norderstedt, Germany),
Ethilon 4-0, Polyamide).
For tissue transportation, the entire explant was submerged in RPMI 1640 supplemented with
120 µg/mL lincomycin, 10 µg/mL colistin and 50 µg/mL vancomycin. On the first day of the study,
a cross section was excised from each explant as a reference sample. Furthermore, epidermis and
dermis tissues were prepared by surgical separation. Epidermis and dermis samples were snap-frozen
in liquid nitrogen immediately after separation until further analysis. Cross sections were stored in
4% paraformaldehyde at room temperature until further histological assessment. For each patient
half of all organ culture samples, already fixed on a frame, were wounded by sharp incision of 10 mm
length and 2 mm depth. Subsequently, all lacerated skin samples were adapted with simple interrupted
suture using 3-0 non-absorbable sutures (Ethicon, Ethilon 3-0, polyamide 6, black).
After mounting, lacerating and suturing the skin samples were placed in a culture chamber
with culture medium composed of DMEM/Ham F12 supplemented with 8 µL/mL 20% bovine
serum albumin, 0.4 µg/mL hydrocortisone, 0.12 IU/mL insulin, 100 IU/mL G penicillin, 20 µg/mL
gentamycin, 1 µg/mL amphotericin B and 50 µg/mL ascorbic acid. The samples were stored at 32 ◦C.
The organ culture medium was changed twice a week.
3.3. RNA Extraction and qPCR
Skin specimens of five patients were included in the study. The RNA from epidermis and
dermis samples (n = 5 samples per group) was extracted using TRIzol®Reagent (Thermo Fischer
Scientific). All samples were weighed. Subsequently, the extraction was performed as proposed
by the manufacturer’s protocol [70]. The RNA content was checked for purity using a Nanodrop
spectrophotometer (Thermo Scientific). cDNA synthesis and qPCR were performed as previously
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described by Kopp et al. [29]. qPCR was performed using the 7500 Real-Time PCR System (Applied
Biosystems, Darmstadt, Germany). cDNA-selective-primers were synthesized by TIB Molbiol
(Berlin, Germany) and are listed in Table 1. The primers (sequences given in Table 2) were designed
using Primer Express (Applied Biosystems) to have a Tm of ~60 ◦C and to span exon-exon boundaries.
All samples were measured in triplicate. For normalization, TATA-binding protein (TBP) was used
as a housekeeping gene. The comparative CT (∆∆CT) method was used for relative quantification of
transcription levels and the 0 days group was defined as 100% for reference.
Table 2. Primer sequences for qPCR.
Gene Primer Name Sequence
TBP TATA-F GTGACCCAGCATCACTGTTTC
TATA-R GCAAACCAGAAACCCTTGCG
APAF1 APAF1-F GGAGGATATATTAAGTGGTGGAACG
APAF1-R GTTTTGAAGTCAGGGGACACG
BAX BAX-F GTCAGCTGCCACTCGGAAA
BAX-R AGTAACATGGAGCTGCAGAGGAT
BCL2 BCL2-F CCTGTGGATGACTGAGTACCTGAA
BCL2-R TCAGAGACAGCCAGGAGAAATCA
BIRC2 BIRC2-F GCTTTTGTTGTGATGGTGGCT
BIRC2-R ACTCACACCTTGGAAACCACT
BIRC3 BIRC3-F TGCTGTGATGGTGGACTCAG
BIRC3-R ACTCACACCTTGGAAACCACT
BIRC5 BIRC5-F GCCAGATGACGACCCCATAG
BIRC5-R CACCAAGGGTTAATTCTTCAAACTG
CASP3 CASP3-F AACTGCTCCTTTTGCTGTGATCT
CASP3-R GCAGCAAACCTCAGGGAAAC
CASP8 CASP8-F TGCAAAAGCACGGGAGAAAG
CASP8-R CTCTTCAAAGGTCGTGGTCAAAG
CASP9 CASP9-F CTCCAACATCGACTGTGAGAAGTT
CASP9-R GCGCCAGCTCCAGCAA
CASP10 CASP10-F GACAAGGAAGCCGAGTCGTA
CASP10-R GCCTCTGTGGTTCCGATTCA
CYC1 CYC1-F CACTGCGGGAAGGTCTCTAC
CYC1-R GGGGTGCCATCGTCAAACTC
FADD FADD-F CCTGGGGAAGAAGACCTGTGTG
FADD-R TCGATGCTGTCGATCTTGGTG
FAS FAS-F AGTCTGGTTCATCCCCATTGAC
FAS-R AGGGATTGGAATTGAGGAAGACT
FASL FASL-F CTTCACTCCAGAAAGCAGGACAAT
FASL-R AGGGATTGGAATTGAGGAAGACT
FN1 FN1-F AGATCTACCTGTACACCTTGAATGACA
FN1-R CATGATACCAGCAAGGAATTGG
LAMA3 LAMA3-F AAAGCAAGAAGTCAGTCCAGC
LAMA3-R TCCCATGAAGACCATCTCGG
P53 P53-F CCTGGATTGGCCAGACTGC
P53-R TTTTCAGGAAGTAGTTTCCATAGGT
RELA RELA-F CGCTTCTTCACACACTGGATTC
RELA-R ACTGCCGGGATGGCTTCT
SPP1 SPP1-F CGAGGTGATAGTGTGGTTTATGGA
SPP1-R CGTCTGTAGCATCAGGGTACTG
All sequences are given in 5′-3′ direction.
Int. J. Mol. Sci. 2017, 18, 2604 17 of 22
3.4. Histochemistry and Microscopy
Hematoxylin–eosin- and Elastica-van-Gieson-staining procedures were used to evaluate the
tissue morphology for each cross section. The methods were published earlier [29]. All sections were
visualized by light microscopy. The samples were investigated by microscopy using a LEICA DM2000
microscope equipped with a Leica DFC310 FX digital CCD color camera.
3.5. TUNEL Assay
TUNEL staining was done according to the manual provided by the manufacturer
(Calbiochem® (Merck Millipore, Darmstadt, Germany), FragEL™ DNA Fragmentation Detection
Kit, Fluorescent—TdT Enzyme) [71]. Stained samples were investigated utilizing a Leica DM
2000 microscope connected to an external light source, Leica EL 6000 (Leica Microsystems GmbH,
Wetzlar, Germany). Palatine tonsil cross-sections were taken as positive control using an objective with
a calibrated magnification of 200×. Microscopic pictures of full-thickness skin grafts were created at
100×magnification.
3.6. Propidium Iodide Staining
For propidium iodide (PI) staining (Sigma-Aldrich) skin tissue specimens were fixed with
paraformaldehyde and embedded in paraffin [72]. 5-µm sections were prepared. The slides were
analyzed by confocal laser-scanning microscopy. Fluorescent staining was analyzed using a Zeiss
LSM 710 CLSM (Zeiss, Jena, Germany) fitted with a Plan-Apochromat 63 × 1.4 objective as previously
described [73]. The PI-stained slides were performed in triplicates.
3.7. Western Blot Analysis
Whole cell lysates were used for Western blotting following conventional protocols for gel
electrophoresis and trans-blotting, as described earlier [31,65,66]. Equal amounts of 10 µL lysate
containing 2 µg/µL protein were loaded on precast TGX stain-free gels (Bio-Rad, Munich, Germany).
Transturbo blot PVDF membranes (Bio-Rad) were used for blotting. An overview of the used antibodies
and their applied concentrations is given in Table 3. The analysis was performed using ImageQuant™
LAS 4000 (GE Healthcare UK Limited, Buckinghamshire, UK), and the densitometry was performed
using ImageJ (NIH). In addition, we used protein from the colon carcinoma cell subline CX+ with high
HSP70 as positive control for caspase-3 [74] and protein from NIH 3T3 fibroblasts, established from a
NIH Swiss mouse embryo (Sigma-Aldrich).
Table 3. Antibodies applied for Western blot analysis.
Primary Antibody Company Dilution Molecular Weight (kDa) Catalogue Number
Caspase-3 Abcam 1:1000 31, 21–14 Ab13585
β-actin Sigma 1:1000 42 A5316
The corresponding secondary antibodies—HRP-linked anti-mouse IgG (#7076) and anti-rabbit IgG (#7074, both Cell
Signaling Technology, Danvers, MA, USA)—were used at a dilution of 1:3000.
3.8. STRING Analysis
Interactions between the components, whose genes were investigated, were determined using
the STRING platform [75]. For each component, the UniProtKB entry number was inserted in
the input form “multiple proteins” and “Homo sapiens” was selected as organism. The resulting
network view was transferred to the interaction view [76,77] and downloaded. Yellow lines show
transcriptional regulation, blue lines show binding, red lines indicate inhibition and black lines point
to posttranslational modification.
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3.9. Statistical Evaluation
Statistical Evaluation was performed using SPSS 24.0 (SPSS, Inc., Chicago, IL, USA). The Mann-
Whitney-U-Test was used to compare the different conditions. All data is presented as mean± standard
deviation (SD) with a significance level of * p < 0.05. indicates the comparison of reference
vs. non-wounded, ** indicates the comparison of reference vs. unwounded skin sample.
4. Conclusions
Regarding the first goal of the study, our data clearly demonstrate that it is possible to maintain live
skin tissue cultures for 10 days on normal ground level and prove their applicability for a spaceflight
experiment. This newly designed wound-healing model by our international space science team has
proven to be suitable for future spaceflights. The viability of the tissue specimens was demonstrated,
no significant signs of cell death (apoptosis/necrosis) were detected in no wound and sutured wound
healing models. With respect to the gene expression analysis, comprising the second goal of the
study, we comprehensively demonstrated the interplay of activators and inhibitors of apoptosis and
extracellular components in ex vivo wound healing models. FAS, CASP9 and CASP10 (all apoptosis
activators), BIRC2, BIRC3 and BIRC5 (apoptosis inhibitors), RELA as well as FN1 (encoding an ECM
protein) were significantly altered in the dermis of no wound samples. The expression of the genes
FN1, CASP9, P53, BIRC3 and BIRC5 was also significantly altered in the epidermis of no wound
samples. CASP9, BIRC2, BIRC3 and BIRC5 mRNAs were significantly changed in the epidermis of
wound samples. In addition, FN1, FAS, BIRC2, BIRC 3 and RELA mRNAs were significantly altered in
the dermis of wound samples. Their interplay in the regulation of apoptosis and cell survival is given
in Figure 9.
The STRING analysis demonstrated that NF-κB exerts a strong regulatory effect. As the NF-κB
gene is upregulated, it might hence play an important role in the inhibition of apoptosis. Furthermore,
the analysis suggested that the upregulated RELA, BIRC2 and BIRC3 genes could enforce the observed
inhibition of apoptosis. Therefore, the data obtained from analyzing the key factors of the intrinsic and
extrinsic pathways of apoptosis support the findings of goal 1.
Concerning the third and last goal of our study, the performed methods in Sections 2.1 and 2.2
demonstrated to be applicable for post-flight analyzes of tissue specimens after the download of
the samples.
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Abbreviations
APAF-1 Apoptotic protease-activating factor 1
BIRC5 Apoptosis inhibitor surviving
BAX Apoptosis regulator Bax (BCL2 associated athanogene) gene
BCL2 Apoptosis regulator Bcl-2 (B-cell lymphoma protein 2) gene
Caspase-3 Cysteinyl aspartic acid-protease-3
Caspase-6 Cysteinyl aspartic acid-protease-6
Caspase-7 Cysteinyl aspartic acid-protease-7
Caspase-8 Cysteinyl aspartic acid-protease-8
Caspase-9 Cysteinyl aspartic acid-protease-9
Caspase-10 Cysteinyl aspartic acid-protease-10
CYC1 Cytochrome C gene
DAPI 4′,6-Diamidin-2-phenylindol
ECM Extracellular Matrix
FADD Fas-associated death domain
FAS/CD95 Tumor necrosis factor receptor superfamily member 6
FN1 Fibronectin gene
IAP Inhibitor of Apoptosis Proteins
RIP Cell death protein RIP
TNFA Tumor necrosis factor α
TNFB Lymphotoxin-α
TRAF2 TNF receptor-associated factor 2
TRAIL Tumor necrosis factor ligand superfamily member 10
TUNEL Terminal deoxynucleotidyl transferase dUTP nick end labeling
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